Agnieszka Stys
Overview
Explore the profile of Agnieszka Stys including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milczarek A, Starzynski R, Stys A, Jonczy A, Staron R, Grzelak A, et al.
PLoS One
. 2017 May;
12(5):e0176800.
PMID: 28542246
Iron regulatory protein 1 (IRP1) is a cytosolic bifunctional [4Fe-4S] protein which exhibits aconitase activity or binds iron responsive elements (IREs) in untranslated regions of specific mRNA encoding proteins involved...
2.
Rzepecka I, Szafron L, Stys A, Felisiak-Golabek A, Podgorska A, Timorek A, et al.
Gynecol Oncol
. 2016 Dec;
144(2):369-376.
PMID: 27939982
Objective: TP53 mutation is the most frequent molecular event in BRCA1-associated ovarian carcinomas. TP53 status may be a confounding factor in the evaluation of clinical importance of other proteins. We...
3.
Gajowiak A, Stys A, Starzynski R, Staron R, Lipinski P
Postepy Hig Med Dosw (Online)
. 2016 Jul;
70(0):709-21.
PMID: 27356602
Iron is essential for all mammalian cells, but it is toxic in excess. Our understanding of molecular mechanisms ensuring iron homeostasis at both cellular and systemic levels has dramatically increased...
4.
Gajowiak A, Stys A, Starzynski R, Bednarz A, Lenartowicz M, Staron R, et al.
Front Mol Neurosci
. 2016 Jan;
8:82.
PMID: 26778957
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by degeneration and loss of motor neurons in the spinal cord, brainstem and motor cortex. Up to 10% of ALS...
5.
Lipinski P, Starzynski R, Stys A, Gajowiak A, Staron R
Postepy Hig Med Dosw (Online)
. 2014 May;
68:557-70.
PMID: 24864106
Heme, a ferrous iron protoporphyrin IX complex, is employed as a prosthetic group in a number of diverse heme proteins that participate in important cellular and systemic physiological processes. Provision...
6.
Starzynski R, Laarakkers C, Tjalsma H, Swinkels D, Pieszka M, Stys A, et al.
PLoS One
. 2013 Jun;
8(5):e64022.
PMID: 23737963
The aim of the study was to establish an optimized protocol of iron dextran administration to pig neonates, which better meets the iron demand for erythropoiesis. Here, we monitored development...
7.
Goula A, Stys A, Chan J, Trottier Y, Festenstein R, Merienne K
PLoS Genet
. 2012 Dec;
8(11):e1003051.
PMID: 23209427
The expansion of CAG/CTG repeats is responsible for many diseases, including Huntington's disease (HD) and myotonic dystrophy 1. CAG/CTG expansions are unstable in selective somatic tissues, which accelerates disease progression....
8.
Starzynski R, Canonne-Hergaux F, Lenartowicz M, Krzeptowski W, Willemetz A, Stys A, et al.
Biochem J
. 2012 Sep;
449(1):69-78.
PMID: 22992020
HO1 (haem oxygenase 1) and Fpn (ferroportin) are key proteins for iron recycling from senescent red blood cells and therefore play a major role in controlling the bioavailability of iron...
9.
Lipinski P, Stys A, Starzynski R
Cell Mol Life Sci
. 2012 May;
70(1):23-38.
PMID: 22581367
Molecular iron metabolism and its regulation are least well understood in the fetal and early postnatal periods of mammalian ontogenic development. The scope of this review is to summarize recent...
10.
Rzepecka I, Szafron L, Stys A, Bujko M, Plisiecka-Halasa J, Madry R, et al.
Cancer Genet
. 2012 Apr;
205(3):94-100.
PMID: 22469508
BRCA1 dysfunction may occur by different mechanisms that are rarely evaluated concomitantly. We aimed to analyze BRCA1 germline mutations, loss of heterozygosity (LOH) and promoter methylation in unselected ovarian carcinomas...